AdjuTec advances toward phase I with regulatory green light

Preparing to hit the clinical stage with its antibiotic resistance breakers, Norwegian AdjuTec Pharma recently got a goahead from the Swedish Medical Products Agency.

The company now hopes to begin single ascending dose studies after the summer break. – The team has done a great job in preparing the clinical trial application.